Prevalence, types and possible causes of insomnia in a Swiss remand prison

European Journal of Epidemiology

Volumn 19, Issue 7, 2004, Pages 665-677

  Elger, Bernice S ^a  

^a UNIVERSITY CENTER OF LEGAL MEDICINE   (Switzerland)

Author keywords

Insomnia; Prevalence; Primary care; Prison; Substance misuse (SM)

Indexed keywords

ANALGESIC AGENT; PSYCHOTROPIC AGENT;

ADULT; ANXIETY; ARTICLE; CONSULTATION; CONTROLLED STUDY; DEPRESSION; FEMALE; GENERAL PRACTITIONER; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; OUTPATIENT CARE; PRESCRIPTION; PREVALENCE; PRISONER; PROSPECTIVE STUDY; QUESTIONNAIRE; STATISTICAL ANALYSIS; SWITZERLAND;

ANXIETY; FEMALE; HUMANS; MALE; PHYSICIANS, FAMILY; PREVALENCE; PRISONERS; PROSPECTIVE STUDIES; QUESTIONNAIRES; SLEEP INITIATION AND MAINTENANCE DISORDERS; SWITZERLAND;

EID: 4644261251     PISSN: 03932990     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:EJEP.0000036805.58237.e3     Document Type: Article

References (38)

1. Jaeger M, Monceau M. La consommation des médicaments psychotropes en prison. Ramonville Saint-Agne: Editions Erés, 1996.
2. Vasseur V. Médecin chef à la prison de la santé. Paris: Le Livre de Poche, 2001.
3. Turnbull P, Stimson GV. Drug use in prison. Br Med J 1994; 308: 1716.
4. Korte T, Pykalainen J, Seppala T. Drug abuse of Finnish male prisoners in 1995. Forensic Sci Int 1998; 97: 171-183.
5. Brooke D, Taylor C, Gunn J, Maden A. Substance misusers remanded to prison - a treatment opportunity? Addiction 1998; 93: 1851-1856.
6. Brooke D, Taylor C, Gunn J, Maden A. Point prevalence of mental disorder in unconvicted male prisoners in England and Wales. Br Med J 1996; 313: 1524-1527.
7. Birmingham L, Mason D, Grubin D. Prevalence of mental disorder in remand prisoners: Consecutive case study. Br Med J 1996; 313: 1521-1524.
8. Harding T. Dépression en milieu carcéral (IIe rencontre Internationale 'Psychiatrie et Epidémiologie' Genève 17-19 mars 1983). Psychologie Médicale 1984; 16: 835-839.
9. Andersen HS, Sestoft D, Lillebaek T, Gabrielsen G, Hemmingsen R, Kramp P. A longitudinal study of prisoners on remand: Psychiatric prevalence, incidence and psychopathology in solitary vs. non-solitary confinement. Acta Psychiatr Scand 2000; 102: 19-25.
10. Harding T, Zimmermann E. Psychiatric symptoms, cognitive stress and vulnerability factors. A study in a remand prison. Br J Psychiatry 1989; 155: 36-43.
11. Lessenger JE. Health care in jails: A unique challenge in medical practice. Postgrad Med 1982; 72: 131-134, 137, 141-144.
12. Nurse J, Woodcock P, Ormsby J. Influence of environmental factors on mental health within prisons: Focus group study. Br Med J 2003; 327: 480.
13. Levin BH, Brown WE. Susceptibility to boredom of jailers and law enforcement officers. Psychol Rep 1975; 36: 190.
14. Elger BS, Goehring C, Antonini Revaz S, Morabia A. Prescription of hypnotics and tranquillisers at the Geneva prison's outpatient service in comparison to an urban outpatient medical service. Soz Praventivmed 2002; 47: 39-43.
15. Kupfer DJ, Reynolds CF. Management of insomnia. N Engl J Med 1997; 336: 341-346.
16. Bourgeois D. Troubles du sommeil en milieu carcéral [Sleep disorders in prison]. Encephale 1997; 23: 180-183.
17. Barnas C, Rossmann M, Roessler H, Riemer Y, Fleischhacker WW. Benzodiazepines and other psychotropic drugs abused by patients in a methadone maintenance program: Familiarity and preference. J Clin Psychopharmacol 1992; 12: 397-402.
18. Socares BG, Lima MS, Reisser AA, Farrell M. Dopamine agonists for cocaine dependence. Cochrane Database Syst Rev 2003; 2: CD003352.
19. Staedt J, Wassmuth F, Stoppe G, et al. Effects of chronic treatment with methadone and naltrexone on sleep in addicts. Eur Arch Psychiatry Clin Neurosci 1996; 246: 305-309.
20. Schenck CH, Mahowald MW, Sack RL. Assessment and management of insomnia. JAMA 2003; 289: 2475-2479.
21. Gowing L, Ali R, White J. Buprenorphine for the management of opioid withdrawal. Cochrane Database Syst Rev 2002; 2: CD002025.
22. Eichenberger G. Les médicaments en prison préventive. Der Strafvollzug in der Schweiz 1978; 2: 81-92.
23. Hohagen F, Rink K, Kappler C, et al. Prevalence and treatment of insomnia in general practice. A longitudinal study. Eur Arch Psychiatry Clin Neurosci 1993; 242: 329-336.
24. Shochat T, Umphress J, Israel AG, Ancoli-Israel S. Insomnia in primary care patients. Sleep 1999; 22(Suppl 2): S359-S365.
25. Simon GE, VonKorff M. Prevalence, burden, and treatment of insomnia in primary care. Am J Psychiatry 1997; 154: 1417-1423.
26. Schramm E, Hohagen F, Kappler C, Grasshoff U, Berger M. Mental comorbidity of chronic insomnia in general practice attenders using DSM-III-R. Acta Psychiatr Scand 1995; 91: 10-17.
27. Quera-Salva MA, Orluc A, Goldenberg F, Guilleminault C. Insomnia and use of hypnotics: Study of a French population. Sleep 1991; 14: 386-391.
28. Ohayon M, Caulet M, Lemoine P. Sujets ages, habitudes de sommeil et consommation de psychotropes dans la population francaise [The elderly, sleep habits and use of psychotropic drugs by the French population]. Encephale 1996; 22: 337-350.
29. Ohayon MM, Caulet M. Psychotropic medication and insomnia complaints in two epidemiological studies. Can J Psychiatry 1996; 41: 457-464.
30. Ohayon M. Epidemiological study on insomnia in the general population. Sleep 1996; 19: S7-S15.
31. Schmitt BE, Gugger M, Augustiny K, Bassetti C, Radanov BP. Prävalenz von Schlafstörungen bei einer werktätigen Schweizer Population: Ergebnisse einer Fragebogenumfrage [Prevalence of sleep disorders in an employed Swiss population: Results of a questionnaire survey]. Schweiz Med Wochenschr 2000; 130: 772-778.
32. Angst J, Vollrath M, Koch R, Dobler-Mikola A. The Zurich Study. VII. Insomnia: Symptoms, classification and prevalence. Eur Arch Psychiatry Neurol Sci 1989; 238: 285-293.
33. Vollrath M, Wicki W, Angst J. The Zurich study. VIII. Insomnia: Association with depression, anxiety, somatic syndromes, and course of insomnia. Eur Arch Psychiatry Neurol Sci 1989; 239: 113-124.
34. Tan TL, Kales JD, Kales A, Soldatos CR, Bixler EO. Biopsychobehavioral correlates of insomnia. IV: Diagnosis based on DSM-III. Am J Psychiatry 1984; 141: 357-362.
35. Ford DE, Kamerow DB. Epidemiologic study of sleep disturbances and psychiatric disorders. An opportunity for prevention? JAMA 1989; 262: 1479-1484.
36. McCaul ME, Svikis DS, Moore RD. Predictors of outpatient treatment retention: Patient versus substance use characteristics. Drug Alcohol Depend 2001; 62: 9-17.
37. Zimmermann E, von Allmen M. Consultations médicales et consommations médicamenteuses en cours de détention préventive à la prison de Champ-Dollon. Soz Praventivmed 1985; 30: 312-321.
38. McElrath K. A comparison of two methods for examining inmates' self-reported drug use. Int J Addict 1994; 29: 517-524.